Techniques like ion-pairing reversed-phase liquid chromatography (IP-RPLC) are widely used to monitor peptide critical quality attributes (CQAs), with hyphenated LC-MS approaches playing a key role in enhancing sensitivity and selectivity, enabling quantification of low-level impurities
The Medicare GLP1 Bridge program Starting July 1, 2026, the Medicare GLP1 Bridge provides coverage for GLP1 weight-loss medications for the first time under a temporary demonstration program
bioequivalence is concluded if certain criteria are met, including, but not limited to, the ratio of these pharmacokinetic (PK) parameters between the test and reference formulations falling between prespecified criteria with a certain assurance, which vary by each respective guideline [28,29,30]
Scientific Evidence: Does Glutathione Aid in Weight Loss
Common reasons for switching include tolerability issues, medication supply shortages, inadequate weight loss response, or NHS commissioning changes
